Welcome to our dedicated page for Barclays Plc SEC filings (Ticker: BCLYF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Barclays PLC (BCLYF) SEC filings page on Stock Titan aggregates the company’s U.S. regulatory disclosures, with AI-powered tools to help interpret complex banking documents. Barclays files as a foreign issuer on Form 20-F and uses Form 6-K to furnish information originally released to The London Stock Exchange, covering topics that range from capital strength to share capital changes.
For users tracking Barclays’ capital position, the filings include a detailed statement on the Bank of England’s 2025 bank capital stress test. This disclosure presents common equity Tier 1, Tier 1 capital, total capital and leverage ratios, along with explanations of how these measures are defined under the UK Capital Requirements Regulation and the PRA Rulebook. AI-generated summaries can highlight the key ratios and what they imply for the bank’s resilience under stress scenarios.
Investors interested in equity structure and dilution can review multiple 6-K reports on transactions in Barclays’ own ordinary shares. These filings describe share buy-back programmes, daily purchases on the London Stock Exchange, the intention to cancel repurchased shares and the resulting issued share capital and total voting rights. Stock Titan’s interface, combined with AI, can make it easier to follow how these programmes affect outstanding shares over time.
This page also surfaces notifications of transactions by persons discharging managerial responsibilities and persons closely associated with them, which detail insider dealings in ordinary shares and American Depositary Shares. In addition, a Form 25 filing by the New York Stock Exchange LLC documents the removal from listing and/or registration of Barclays’ 4.375% Fixed Rate Senior Notes due 2026. Real-time updates from EDGAR, together with AI explanations, help users navigate these filings without reading every technical paragraph.
Barclays PLC reports updated share capital and ongoing buy-backs in a Form 6-K summarising multiple London Stock Exchange announcements. As of 31 December 2025, issued share capital consisted of 13,864,768,457 ordinary shares with voting rights and no treasury shares.
Through daily transactions between 2 and 29 January 2026, Barclays purchased its own ordinary shares on the London Stock Exchange from Citigroup Global Markets Limited as part of the buy-back programme announced on 23 October 2025. Each daily tranche is being cancelled in full, steadily reducing the share count.
After cancelling the shares bought on 29 January 2026, issued share capital stands at 13,817,148,746 ordinary shares with voting rights. The company also provides a block listing interim review for several employee and incentive share schemes, detailing unallotted ordinary shares reserved under each plan as of 31 December 2025.
Barclays PLC is having its 4.375% Fixed Rate Senior Notes due 2026 removed from listing and/or registration on the New York Stock Exchange LLC. The Exchange filed a Form 25, stating that it has followed its own rules under 17 CFR 240.12d2-2(b) to strike this class of securities from listing and registration.
The filing also notes that Barclays PLC has followed the Exchange's rules and the requirements of 17 CFR 240.12d2-2(c) for the voluntary withdrawal of this class of notes. The notification is signed on behalf of the NYSE by an authorized officer, confirming the Exchange believes it meets all requirements to submit this delisting notice.
Barclays PLC reports extensive share activity in December 2025, mainly driven by its previously announced buy-back programme. On multiple trading days from late November through 30 December 2025, the bank bought ordinary shares on the London Stock Exchange from Citigroup Global Markets Limited and intends to cancel all of them. After the 28 November purchase and related cancellations, issued share capital consisted of 13,906,092,145 ordinary shares with voting rights, and after the 30 December purchase it will consist of 13,864,674,344 ordinary shares.
The company also discloses routine total voting rights information as of 30 November 2025, confirming 13,906,092,145 ordinary shares in issue and none held in treasury. Several senior executives and other persons discharging managerial responsibilities report transactions in Barclays shares and ADSs, including disposals via the nominee service, deliveries of shares under employee and remuneration plans, and sales to cover tax and social security liabilities. In addition, Barclays has applied to block list 20,000,000 new ordinary shares for issue under the Barclays Group Share Value Plan, which will rank equally with existing shares when admitted.
Barclays PLC reports the results of the Bank of England’s 2025 capital stress test, confirming that the bank remains sufficiently capitalised throughout the adverse scenario. The test shows a minimum stressed Common Equity Tier 1 (CET1) ratio of 8.8% before and 9.3% after strategic management actions, compared with a minimum requirement of 7.2%. Barclays’ actual CET1 ratio was 13.6% as of 31 December 2024 and 14.1% in Q3 2025, supporting its stated capital target range of 13–14%.
The Tier 1 leverage ratio fell to a minimum stressed level of 4.0% before and 4.2% after management actions, versus a minimum requirement of 3.25%, compared with actual levels of 5.0% at year-end 2024 and 4.9% in Q3 2025. Total capital and Tier 1 capital ratios also remained above stressed low points and requirements, underscoring Barclays’ description of its balance sheet as robust and resilient.
Barclays PLC reports a series of November 2025 share repurchases and related share capital updates. On multiple trading days between 31 October and 27 November 2025, the bank bought back and intends to cancel blocks of ordinary shares of 25 pence each on the London Stock Exchange, with daily volumes typically between about 2 million and 4 million shares and prices generally in the 390p–430p range.
As of 31 October 2025, Barclays’ issued share capital consisted of 13,922,759,891 ordinary shares with voting rights, falling to 13,907,858,099 after the 27 November 2025 cancellation. Since the commencement of the buy-back programme announced on 30 July 2025, the bank reports that by 25 November 2025 it had purchased 261,554,089 ordinary shares on the London Stock Exchange at a volume weighted average price of 381.4737p per share. The filing also discloses routine management share dealings under employee and nominee arrangements.
Barclays PLC has completed its HY 2025 share buy-back and is starting a new programme. On 26 November 2025 it bought 539,869 ordinary shares at a volume weighted average price of 414.9236p for cancellation. After cancelling these and prior repurchases, the issued share capital will be 13,909,748,427 ordinary shares with voting rights.
Since the HY 2025 buy-back began, Barclays has repurchased 262,093,958 ordinary shares at a volume weighted average price of 381.5426p, for total consideration of approximately £1 billion. The company will now commence its Q3 2025 buy-back, previously announced on 23 October 2025, to purchase ordinary shares for up to £500m, with a maximum of 1,174,692,434 shares eligible for repurchase.
Barclays PLC (BCS) filed a Form 13F holdings report listing institutional equity positions. The filing reports 11,877 information table entries with an aggregate value of $461,228,194,391. The report includes 6 other managers. It was signed by Suejean Mott, Director, in Whippany, NJ on 11-12-2025.
Other included managers named in the filing include Barclays Bank PLC, Barclays Capital Inc., Barclays Capital Securities Ltd, Barclays Bank (Suisse) SA, Barclays Capital Luxembourg SaRL, and Barclays Investment Solutions Ltd.
Barclays PLC announced the full redemption of its $1,500,000,000 6.125% Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities, with redemption set for December 15, 2025.
The notes will be redeemed at 100% of principal plus accrued and unpaid interest from, and including, September 15, 2025 to, but excluding, the redemption date. On that date, the redemption price becomes due and interest will cease to accrue. Prior to redemption, Barclays will irrevocably deposit funds sufficient to pay the total redemption price with the trustee or a paying agent.
The listing of these securities on the London Stock Exchange’s International Securities Market will be canceled on, or shortly after, December 15, 2025. Holders may surrender securities and receive payment via The Bank of New York Mellon, 160 Queen Victoria Street, London EC4V 4LA.
Barclays PLC filed a Form 6-K detailing October updates to its ongoing share buy-back announced on 30 July 2025. The company reported multiple daily repurchases on the London Stock Exchange, each intended for cancellation. As of the purchase dated 30 October 2025, cumulative repurchases since programme commencement reached 205,529,348 ordinary shares at a volume‑weighted average price of 374.4285p per share.
Following each cancellation, Barclays disclosed the updated share count; after the 30 October purchases, issued share capital stood at 13,926,591,777 ordinary shares with voting rights. The filing also notes a block listing application for 68,000,000 shares for employee share schemes, with admission expected to be effective on 16 October 2025, and routine disclosures of director/PDMR share transactions. Barclays states there are no ordinary shares held in Treasury.
Barclays PLC (BCS): NYSE filed Form 25 to remove a debt security from listing and/or registration. The action covers Barclays’ 7.325% Fixed Rate Resetting Senior Callable Notes due 2026 on the New York Stock Exchange. The filing states the Exchange has complied with its rules under 17 CFR 240.12d2-2(b), and notes issuer compliance under 17 CFR 240.12d2-2(c) for voluntary withdrawal procedures.